TUG1 and colorectal carcinoma: As displayed in Figure 5(a), the interference with lncRNA TUG1 and oxaliplatin treatment both restrained the tumor growth of CRC, and this trend was more obvious in the Lv-shTUG1+oxaliplatin (OXA) group.